Christopher Keenan | VP, IR |
Sean McCarthy | President, CEO, and Chairman |
Carlos Campoy | SVP and CFO |
Christopher Marai | Nomura Instinet |
Terence Flynn | Goldman Sachs |
Robert Burns | H.C. Wainwright |
Boris Peaker | Cowen |
Mara Goldstein | Mizuho |
Etzer Darout | Guggenheim Securities |
Joseph Catanzaro | Piper Sandler |
Mohit Bansal | Citigroup |
Biren Amin | Jefferies |
Good day, ladies and gentlemen, and welcome to the CytomX Therapeutics First Quarter 2020 Financial Conference Call. At this time, all participants are in a listen-only mode.
As a reminder, this call may be recorded.
I would now like to introduce your host for today's conference, Christopher Keenan, Vice President of Investor Relations. Chris, you may begin.